Merck reports that its animal health segment “offers an extensive suite of digitally connected identification, traceability and monitoring products,” reflecting an investment in connectivity and digital technologies to support veterinary customers and supply-chain transparency; the company also describes how it “is working cross-functionally across the globe to monitor and mitigate interruptions to business continuity resulting from the war, including its impact on Merck’s supply chain, operations and clinical trials,” illustrating the coordination of internal processes and assets to manage external risks; likewise, Merck acknowledges “some minor disruption and volatility in its global supply chain network,” implying the need for integrated information systems and operational flexibility to allocate resources, maintain market responsiveness and support organizational resilience.